市場調查報告書

全球人乳寡糖 (HMO) 市場:趨勢及預測(2019年∼2025年)

Global Human Milk Oligosaccharides Market - Trends & Forecast, 2019-2025

出版商 Market Research Future 商品編碼 911169
出版日期 內容資訊 英文 88 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球人乳寡糖 (HMO) 市場:趨勢及預測(2019年∼2025年) Global Human Milk Oligosaccharides Market - Trends & Forecast, 2019-2025
出版日期: 2019年08月31日內容資訊: 英文 88 Pages
簡介

全球人乳寡糖 (HMO) 市場在2018年估算為1億1,003萬美金。該市場至2025年預計將以27.06%的年複合成長率成長。

本報告提供全球人乳寡糖 (HMO) 市場的相關調查,市場機會和課題,成長及阻礙因素,各類型、用途、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場介紹

第3章 調查方法

第4章 市場動態

  • 簡介
  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場要素分析

  • 波特的五力分析

第6章 市場分析:各類型

  • 概要
  • 中性
  • 酸性

第7章 市場分析:各用途

  • 概要
  • 食品產業
  • 在研究所的研究

第8章 市場分析:各地區

  • 概要
  • 北美
  • 歐洲
  • 中國
  • 日本

第9章 競爭情形

  • 概要
  • 競爭基準
  • 市場開發數量的主要企業
  • 主要開發分析
    • 產品的銷售
    • 法規當局的認證
    • 合併及收購
    • 擴張
    • 合資企業

第10章 企業簡介

  • Abbott
  • BASF SE
  • Dextra Laboratories Limited
  • DuPont Nutrition & Health
  • Elicityl S.A.
  • Glycom
  • Glycosyn LLC
  • Inbiose
  • Jennewein Biotechnologie GmbH
  • Medolac Laboratories
  • Nestle Health Science
  • ZuChem

第11章 附錄

目錄

Human Milk Oligosaccharides Market Research Report - Global Forecast till 2025

Global Human Milk Oligosaccharides Market Information: Information by Type (Neutral and Acidic), Application (Food Industry and Laboratory Research) and Region (North America, Europe, China and Japan) - Forecast till 2025

Market Analysis

After fats and carbohydrates, the third most abundant ingredient in human breast milk is Human milk oligosaccharides (HMOs). They are sugar molecules and found in high concentrations in breast milk.

To the increasing application of HMOs in functional foods and rising demand in infant formula leads to the growth "The global human milk oligosaccharides market". However, the high cost of production is hindering the growth of the global human milk oligosaccharides market.

From past few years people has become health conscious. This has resulted in thorough changes in the lifestyle and diet. People are driven towards the functional foods, such as dietary supplements and probiotics, globally that's resulted in the rise in demand of the same.

HMOs in functional food products and beverages remove injurious bacteria such as salmonella and campylobacter and help to generate the growth of good bacteria.

The use of HMOs in adult nutrition such as functional foods and supplements is increasing due to their benefits such as refining gut microbiota and enhancing the immune system. These factors are likely to drive the growth of the market during the forecast period. The Global Human Milk Oligosaccharides Market is Expected to Register a CAGR of 27.06% During the Assessment Period with a Market Value of USD 110.03 Million in 2018. In the year 2018 due to the high consumption of infant formula in the region North America accounted for the largest share of the global human milk oligosaccharides market. In the year 2018, the second-largest revenue share of the global market was of Europe. As per the 2017 report published by UNICEF, the UK has one of the lowest rates of breastfeeding in the world, with just 34% of babies receiving breast milk at six months of age.Therefore, the key factors inducing the progress of the European market are the low rates of breastfeeding and increasing EU consents for newly launched HMO-based products. due to the decline in infant population; the Japanese market accounted for a share of 3.26% in 2018 and hence, it held the smallest share of the global human milk oligosaccharides market

Market Segmentation

Global Human Milk Oligosaccharides Market is divided by Type, by application and by region. On the basis of type it is divided into Acidic and Neutral(projected to reach USD 563.13 Million by 2025). On the basis of application it is divided into Food Industry and Laboratory Research. On the basis of region, it is divided in the regions like North America, Europe, China and Japan.

Regional Analysis

The global human milk oligosaccharides market has been divided, based on region, into North America, Europe, China, and Japan.

Major Players

BASF SE (Germany), Dextra Laboratories Limited (UK), DuPont Nutrition & Health (Denmark), Glycom (Denmark), Glycosyn LLC (US), Jennewein Biotechnologie GmbH (Germany), Medolac Laboratories (US), Nestle Health Science (Switzerland) and ZuChem (US), Abbott (US), Elicityl S.A. (France), Inbiose NV (Belgium) are the major players in the Global Human Milk Oligosaccharides Market

Table of Contents

1 Executive Summary

2 Market Introduction

  • 2.1 Definition
  • 2.2 Scope of the Study
  • 2.3 Market Structure

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Rising Application in Functional Foods
    • 4.2.2 Increasing Demand in Infant Formula
    • 4.2.3 Growing Participation by Market Players
  • 4.3 Restraint
    • 4.3.1 High Production Costs
  • 4.4 Opportunity
    • 4.4.1 Expansion in Emerging Economies

5 Market Factor Analysis

  • 5.1 Porter's 5 Forces Analysis
    • 5.1.1 Threat of New Entrants
    • 5.1.2 Bargaining Power of Suppliers
    • 5.1.3 Threat of Substitutes
    • 5.1.4 Bargaining Power of Buyers
    • 5.1.5 Rivalry

6 Global Human Milk Oligosaccharides Market, By Type

  • 6.1 Overview
  • 6.2 Neutral
  • 6.3 Acidic

7 Global Human Milk Oligosaccharides Market, by Application

  • 7.1 Overview
  • 7.2 Food Industry
  • 7.3 Laboratory Research

8 Global Human Milk Oligosaccharides Market, by Region/Country

  • 8.1 Overview
  • 8.2 North America
  • 8.3 Europe
  • 8.4 China
  • 8.5 Japan

9 Competitive Landscape

  • 9.1 Overview
  • 9.2 Competitive Benchmarking
  • 9.3 Leading Player in terms of Number of Developments in Human Milk Oligosaccharides Market
  • 9.4 Key Development Analysis
    • 9.4.1 Product Launch
    • 9.4.2 Regulatory Approval
    • 9.4.3 Merger & Acquisition
    • 9.4.4 Expansion
    • 9.4.5 Joint Venture

10 Company Profiles

  • 10.1 Abbott
    • 10.1.1 Company Overview
    • 10.1.2 Financial Overview
    • 10.1.3 Products/Services Offered
    • 10.1.4 Key Developments
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Strategies
  • 10.2 BASF SE
    • 10.2.1 Company Overview
    • 10.2.2 Financial Overview
    • 10.2.3 Products/Services Offered
    • 10.2.4 Key Developments
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Strategies
  • 10.3 Dextra Laboratories Limited
    • 10.3.1 Company Overview
    • 10.3.2 Financial Overview
    • 10.3.3 Products/Services Offered
    • 10.3.4 Key Developments
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Strategies
  • 10.4 DuPont Nutrition & Health
    • 10.4.1 Company Overview
    • 10.4.2 Financial Overview
    • 10.4.3 Products/Services Offered
    • 10.4.4 Key Developments
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Strategies
  • 10.5 Elicityl S.A.
    • 10.5.1 Company Overview
    • 10.5.2 Financial Overview
    • 10.5.3 Products/Services Offered
    • 10.5.4 Key Developments
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Strategies
  • 10.6 Glycom
    • 10.6.1 Company Overview
    • 10.6.2 Financial Overview
    • 10.6.3 Products Offering
    • 10.6.4 Key Developments
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Strategies
  • 10.7 Glycosyn LLC
    • 10.7.1 Company Overview
    • 10.7.2 Financial Overview
    • 10.7.3 Products/Services Offered
    • 10.7.4 Key Developments
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Strategies
  • 10.8 Inbiose
    • 10.8.1 Company Overview
    • 10.8.2 Financial Overview
    • 10.8.3 Products/Services Offered
    • 10.8.4 Key Developments
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Strategies
  • 10.9 Jennewein Biotechnologie GmbH
    • 10.9.1 Company Overview
    • 10.9.2 Financial Overview
    • 10.9.3 Products Offering
    • 10.9.4 Key Developments
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Strategies
  • 10.1 Medolac Laboratories
    • 10.10.1 Company Overview
    • 10.10.2 Financial Overview
    • 10.10.3 Products/Services Offered
    • 10.10.4 Key Developments
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Strategies
  • 10.11 Nestle Health Science
    • 10.11.1 Company Overview
    • 10.11.2 Financial Overview
    • 10.11.3 Products/Services Offered
    • 10.11.4 Key Developments
    • 10.11.5 SWOT Analysis
    • 10.11.6 Key Strategies
  • 10.12 ZuChem
    • 10.12.1 Company Overview
    • 10.12.2 Financial Overview
    • 10.12.3 Products/Services Offered
    • 10.12.4 Key Developments
    • 10.12.5 SWOT Analysis
    • 10.12.6 Key Strategies

11 Appendix

  • 11.1 References
  • 11.2 Related Reports

List of Tables

  • TABLE 1 SECONDARY RESEARCH
  • TABLE 2 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 3 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET FOR NEUTRAL HMO, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 4 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET FOR ACIDIC HMO, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 5 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 6 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET FOR FOOD INDUSTRY, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 7 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET FOR LABORATORY RESEARCH, BY REGION, 2016-2025 (USD MILLION)
  • TABLE 8 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION/COUNTRY, 2016-2025 (USD MILLION)
  • TABLE 9 NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 10 NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 11 EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 12 EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 13 CHINA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 14 CHINA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 15 JAPAN: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2016-2025 (USD MILLION)
  • TABLE 16 JAPAN: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2016-2025 (USD MILLION)
  • TABLE 17 TOP MANUFACTURERS IN THE GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET
  • TABLE 18 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE HUMAN MILK OLIGOSACCHARIDES MARKET
  • TABLE 19 PRODUCT LAUNCH
  • TABLE 20 REGULATORY APPROVAL
  • TABLE 21 MERGER & ACQUISITION
  • TABLE 22 EXPANSION
  • TABLE 23 JOINT VENTURE

List of Figures

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 RESEARCH PROCESS OF MRFR
  • FIGURE 3 TOP DOWN & BOTTOM UP APPROACH
  • FIGURE 4 DRIVERS, RESTRAINTS, AND OPPORTUNITIES OF GLOBAL ABC MARKET
  • FIGURE 5 PORTER'S 5 FORCES ANALYSIS OF GLOBAL ABC MARKET
  • FIGURE 6 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2018 (%)
  • FIGURE 7 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2018 AND 2025 (USD MILLION)
  • FIGURE 8 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2018 (%)
  • FIGURE 9 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2018 AND 2025 (USD MILLION)
  • FIGURE 10 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION/COUNTRY, 2018 (%)
  • FIGURE 11 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION/COUNTRY, 2018 AND 2025 (USD MILLION)
  • FIGURE 12 NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2018 AND 2025 (USD MILLION)
  • FIGURE 13 NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2018 AND 2025 (USD MILLION)
  • FIGURE 14 EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2018 AND 2025 (USD MILLION)
  • FIGURE 15 EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2018 AND 2025 (USD MILLION)
  • FIGURE 16 CHINA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2018 AND 2025 (USD MILLION)
  • FIGURE 17 CHINA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2018 AND 2025 (USD MILLION)
  • FIGURE 18 JAPAN: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2018 AND 2025 (USD MILLION)
  • FIGURE 19 JAPAN: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2018 AND 2025 (USD MILLION)
  • FIGURE 20 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 21 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, COMPETITIVE LANDSCAPE
Back to Top